Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Uterine Cervical Dysplasia 3Stomach Neoplasms 2Neoplasms 2Atypical Squamous Cells of the Cervix 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Genital Neoplasms, Female 1Genital Diseases, Female 1Genital Diseases 1Female Urogenital Diseases and Pregnancy Complications 1

Interventions

pembrolizumab 7Cisplatin 6Cetuximab 4zalutumumab 3Radiotherapy 2Paclitaxel 2Nivolumab 2Gefitinib 2Fluorouracil 2sintilimab 1osimertinib 1enzalutamide 1durvalumab 1cobimetinib 1atezolizumab 1advexin 1Taxes 1Pemetrexed 1Papanicolaou Test 1Injections, Subcutaneous 1Human Papillomavirus DNA Tests 1Gemcitabine 1Dimethyl Sulfoxide 1Colposcopy 1Cilengitide 1Ascorbic Acid 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms, Squamous Cell × Human Papillomavirus DNA Tests × Clear all
NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plusâ„¢ Pap

Becton, Dickinson and Company

Terminated
5,859 enrolled 4 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡